FindTrial
Sign In

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01621347
Enrollment
26
Registered
2012-06-18
Start date
2012-03-01
Completion date
2012-09-01
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection, Pregnancy

Keywords

HIV, Pregnancy, Postpartum, Women, Medication Adherence

Brief summary

The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.

Detailed description

Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care & community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.

Interventions

None listed

Sponsors

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Lead SponsorOTHER
Centre Hospitalier Universitaire Vaudois
CollaboratorOTHER
Swiss HIV Cohort Study
CollaboratorNETWORK

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pregnant Women * HIV-positive * Antiretroviral medication delivered in electronical monitors

Exclusion criteria

* Monitored period during pregnancy \< 1 month

Design outcomes

Primary

MeasureTime frameDescription
Change in patient adherence during pregnancy and postpartumbefore delivery (1 to 9 month) and postpartum (6 month)By electronic drug monitoring, pill count and subject interviews' marks

Secondary

MeasureTime frameDescription
Adherence barriers and facilitatorspregnancy and postpartum (6 months)Data recorded in subject's interview marks

Countries

Switzerland

Contacts

STUDY_CHAIRMarie-Paule Schneider, PhD

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

PRINCIPAL_INVESTIGATORAurélie Gertsch, PhD-Student

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

STUDY_CHAIROlivier Bugnon, Professor

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

PRINCIPAL_INVESTIGATOROdile Michel, Student

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

STUDY_CHAIRMatthias Cavassini, M.D

Centre Hosppitalier Universitaire Vaudois

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026